The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Or maybe just useless/clueless senior management from the UK?
Wont be a western own business then and better routes to market with potential Taiwanese Gov contracts no doubt??
I was reading this article again and the statement of Inex 2023 forecast surprised me "Inex forecasts the acquisition to contribute $3.5-4 million (SGD $4.7 – 5.4 million) additional revenues to the group in 2023."
https://www.biospectrumasia.com/news/55/22584/singapores-inex-innovate-buys-taiwan-genomics-business-of-yourgene-for-4-m.html
How can Inex literally forecast double the revenue in just 1 year compare to yourgene who has been there in the region for so long ?????
Great point!
When have we received timely TR1 or RNS 😜
If they were accumulating then they would have crossed the threshold for TR1 which would mean the dead cat was out of the bag 🤣
*interim CFO
I don’t think cash is a concern as interim might be keeping a close watch on the cash burn rate because this is his expertise .
This to me appears more of a lowball offer game. And I think they have enough shares by now because is no way a business which is growing especially EMEA and US market, has a patent, good alternate with their edta tube capability and with expected revenue of 20+ million will have a market cap of less than 7million!!
They are sat on commercial news and have mentioned contract wins later in H2. This will all come together around Sep I suggest
Cant risk going into the end of year accounts and AGM without something to secure their overweight salaries
As for cash, they still have the partner to call on yet, so cash is there, but so is the dilution.
They won't pump it up if they want a MBO. or some other lowball reason.
They need to pump up the share price before we contemplate a sale.
Just pump out some commercial news - there must be some - and convince us the cash won’t run out.
Or maybe the cash will run out…
Who knows, but I doubt there is much in it tbh.
The look and feel is similar and the big hype
Clark, sorry don't follow
Was the website a hidden message to LTH???
Step up Mr Leeser, get it done!
I still believe ygen is in good business and is growing. The management though is s***.
If Ambry / labco buys ygen they just have to remove these bunch of a**h*** and we will be EBIDTA positive quickly and SP will sky rocket!!
Someone please save ygen from this incompetent management!!
Yes 97% , some feat that! Mind boggling how some are still in place drawing tens of thousands a month. Why would they want to sell it and lose their jobs?
May be Peter is working with investor and existing management will be thrown out soon ......lack of news is an absolute dampener.
IMO best is to sell this company rather than destroying the stock price which is down by 97% just in 1 year!!
Probably still rolling around the floor laughing at how this company has been run by Coco and the other clowns!
As at 31 March 2023, the Company had cash of £2.8m. As announced on 17 March 2023, Peter Charles was appointed as Interim Chief Financial Officer.
Big play on aligning the website to have the same look and feel as Ambry but no mention of YGEN as a partner or provider? 🧐
Heaven knows! As we've heard zilch I assume not much happening, be it over there or selling their gear over here. Unless they are selling plenty but in smaller quantities, hence not individually material. That's why we didn't get a rns for those new Nipt contracts grossing £2.7M
Where are we with Ambry?
https://www.ambrygen.com